Improving therapeutic strategies for Head and Neck Cancer: Insights from 3D hypoxic cell culture models in treatment response evaluation

被引:0
作者
Ostapowicz, Julia [1 ,2 ,3 ]
Ostrowska, Kamila [2 ,4 ]
Golusinski, Wojciech [4 ]
Kulcenty, Katarzyna [2 ]
Suchorska, Wiktoria M. [1 ,2 ]
机构
[1] Poznan Univ Med Sci, Dept Electroradiol, 15 Garbary St, PL-61866 Poznan, Poland
[2] Greater Poland Canc Ctr, Radiobiol Lab, Poznan, Poland
[3] Poznan Univ Med Sci, Doctoral Sch, Poznan, Poland
[4] Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Head & Neck Surg, Poznan, Poland
来源
ADVANCES IN MEDICAL SCIENCES | 2024年 / 69卷 / 02期
关键词
HNSCC; Head and neck cancer; Hypoxia; 3D; Drug resistance; TUMOR HYPOXIA; INDUCIBLE FACTOR-1-ALPHA; TREATMENT RESISTANCE; TARGETED THERAPY; DOUBLE-BLIND; STEM-CELLS; EXPRESSION; CARCINOMA; RADIATION; MICROENVIRONMENT;
D O I
10.1016/j.advms.2024.07.007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hypoxia in the tumor core negatively affects the outcome of patients with head and neck squamous cell carcinoma (HNSCC). Nevertheless, its role in predicting treatment response requires further exploration. Typically, reduced oxygen levels in the tumor core correlate with diminished efficacy of radiotherapy, chemotherapy, and immunotherapy, which are commonly used for HNSCC patients' treatment. Understanding the mechanistic underpinnings of these varied treatment responses in HNSCC is crucial for enhancing therapeutic outcomes and extending patients' overall survival (OS) rates. Standard monolayer cell culture conditions have major limitations in mimicking tumor physiological features and the complexity of the tumor microenvironment. Threedimensional (3D) cell cultures enable the recreation of the in vivo tumor attributes, encompassing oxygen and nutrient gradients, cellular morphology, and intracellular connections. It is vital to use the 3D model in treatment response studies to mimic the tumor microenvironment, as evidenced by the decreased sensitivity of 3D structures to anticancer therapy. Accordingly, the aim of the study was to delineate the utility of the 3D models of hypoxic head and neck tumors in drug screening and treatment response studies.
引用
收藏
页码:368 / 376
页数:9
相关论文
共 121 条
[81]   HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia [J].
Povero, Davide ;
Chen, Yongbin ;
Johnson, Scott M. ;
McMahon, Cailin E. ;
Pan, Meixia ;
Bao, Hanmei ;
Petterson, Xuan-Mai T. ;
Blake, Emily ;
Lauer, Kimberly P. ;
O'Brien, Daniel R. ;
Yu, Yue ;
Graham, Rondell P. ;
Taner, Timucin ;
Han, Xianlin ;
Razidlo, Gina L. ;
Liu, Jun .
JOURNAL OF HEPATOLOGY, 2023, 79 (02) :378-393
[82]   Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development? [J].
Pozzi, Sabina ;
Scomparin, Anna ;
Dangoor, Sahar Israeli ;
Ajamil, Daniel Rodriguez ;
Ofek, Paula ;
Neufeld, Lena ;
Krivitsky, Adva ;
Vaskovich-Koubi, Daniella ;
Kleiner, Ron ;
Dey, Pradip ;
Koshrovski-Michael, Shani ;
Reisman, Noa ;
Satchi-Fainaro, Ronit .
ADVANCED DRUG DELIVERY REVIEWS, 2021, 175
[83]   Hypoxia-induced HIF1A activates DUSP18-mediated MAPK14 dephosphorylation to promote hepatocellular carcinoma cell migration and invasion [J].
Pu, Jian ;
Qin, Zebang ;
Fang, Quan ;
Huang, Youguan ;
Lu, Yuan ;
Li, Wenchuan ;
Wang, Jianchu ;
Tang, Qianli ;
Zeng, Dongyun ;
Wei, Huamei .
PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
[84]   Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines [J].
Raitanen, Julia ;
Barta, Bernadette ;
Hacker, Marcus ;
Georg, Dietmar ;
Balber, Theresa ;
Mitterhauser, Markus .
CELLS, 2023, 12 (03)
[85]   Imitating Hypoxia and Tumor Microenvironment with Immune Evasion by Employing Three Dimensional In vitro Cellular Models: Impressive Tool in Drug Discovery [J].
Ray, Suman Kumar ;
Mukherjee, Sukhes .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2022, 17 (01) :80-91
[86]   Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02) [J].
Rischin, D ;
Peters, L ;
Fisher, R ;
Macann, A ;
Denham, J ;
Poulsen, M ;
Jackson, M ;
Kenny, L ;
Penniment, M ;
Corry, J ;
Lamb, D ;
McClure, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :79-87
[87]   Hypoxia dynamics on FMISO-PET in combination with PD-1 /PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation [J].
Ruehle, Alexander ;
Grosu, Anca-L ;
Wiedenmann, Nicole ;
Mix, Michael ;
Stoian, Raluca ;
Niedermann, Gabriele ;
Baltas, Dimos ;
Werner, Martin ;
Weber, Wolfgang A. ;
Kayser, Gian ;
Nicolay, Nils H. .
THERANOSTICS, 2020, 10 (20) :9395-9406
[88]   Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment [J].
Ruffin, Ayana T. ;
Li, Housaiyin ;
Vujanovic, Lazar ;
Zandberg, Dan P. ;
Ferris, Robert L. ;
Bruno, Tullia C. .
NATURE REVIEWS CANCER, 2023, 23 (03) :173-188
[89]   Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer [J].
Saha, Santu ;
Howarth, Rachel ;
Sharma-Saha, Sweta ;
Kelly, Charles .
BIOLOGY OPEN, 2023, 12 (05)
[90]   Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion [J].
Sarnella, Annachiara ;
Ferrara, Ylenia ;
Auletta, Luigi ;
Albanese, Sandra ;
Cerchia, Laura ;
Alterio, Vincenzo ;
De Simone, Giuseppina ;
Supuran, Claudiu T. ;
Zannetti, Antonella .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)